Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.
about
Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 MutationsMechanisms and management of diabetic painful distal symmetrical polyneuropathy.Activation of neuronal Kv7/KCNQ/M-channels by the opener QO58-lysine and its anti-nociceptive effects on inflammatory pain in rodents.Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.The preclinical discovery and development of ezogabine for the treatment of epilepsy.
P2860
Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Retigabine (ezogabine) as add- ...... res: an update for clinicians.
@en
type
label
Retigabine (ezogabine) as add- ...... res: an update for clinicians.
@en
prefLabel
Retigabine (ezogabine) as add- ...... res: an update for clinicians.
@en
P2860
P356
P1476
Retigabine (ezogabine) as add- ...... res: an update for clinicians.
@en
P2093
Jacklyn A Harris
Julie A Murphy
P2860
P304
P356
10.1177/2040622311421542
P577
2011-11-01T00:00:00Z